TORONTO--(BUSINESS WIRE)--Cytyc Corporation (Nasdaq: CYTC), a leading provider of surgical and diagnostic products targeting cancer diagnostics and women’s health, today announced that twenty-one scientific abstracts evaluating the performance of the ThinPrep® Imaging System were published in the special programs supplement of the journal Cancer Cytopathology, distributed this week at the 54th Annual Scientific Meeting of the American Society of Cytopathology (ASC) in Toronto. The studies show a variety of benefits including improved disease detection compared to manual screening, evaluation of specimen adequacy, detection of glandular abnormalities, and impact on overall quality and productivity.
